Benicia, CA, United States of America

Amy J Weiner

This inventor holds 19 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Hepatitis C Research. Top assignees: Chiron Corporation, Novartis Vaccines & Diagnostics, Gmbh, The Director General of the National Institute of Health of Japan. Active years: 1994-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amy J Weiner. Retrieved from https://idiyas.com/inventor/amy-j-weiner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19 

% Patents Active = 89.5



Average Co-Inventor Count = 2.5

ph-index = 12

Forward Citations = 497(Granted Patents)


Location History:

  • Oakland, CA (US) (1998)
  • Benicia, CA (US) (1994 - 2008)
  • Fairfield, CA (US) (2009)

Company Filing History:


Years Active: 1994-2009

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Thiosemicarbazones
Hepatitis C Virus
Immunopotentiators
Polypeptides
Genotyping
Infected Cell Systems
Diagnostics
Heteroduplex Tracking Assay
Polynucleotides
Virus Isolates
Immunoreactive Compositions
19 patents (USPTO):Explore Patents

Title: Amy J Weiner: A Pioneer in Virology and Immunology

Introduction

Amy J Weiner, based in Benicia, CA, is a notable inventor with 19 patents to her name. Her work focuses on innovative treatments and methodologies for tackling viral infections, particularly in relation to hepatitis C and immune modulation.

Latest Patents

Among her latest contributions to the field are two significant patents. The first, titled "Thiosemicarbazones as Anti-Virals and Immunopotentiators," presents novel immune potentiators, vaccine adjuvants, and methods for treating viral infections, including Hepatitis C Virus (HCV). This invention outlines a comprehensive approach to modulating immune responses using specific pharmaceutical compositions. The second patent, "Conserved Motif of Hepatitis C Virus E2/NS1 Region," focuses on a newly discovered immunogenic motif within the hypervariable region of the HCV glycoprotein. This discovery holds promise for developing additional diagnostic and therapeutic tools for HCV.

Career Highlights

Amy has had a rich career, contributing significantly to the biotech industry. She has been associated with leading organizations such as Chiron Corporation and Novartis Vaccines & Diagnostics, GmbH. Her innovative research has had a profound impact on the development of antiviral treatments and vaccine formulations.

Collaborations

Throughout her career, Amy has collaborated with esteemed colleagues, including Michael Houghton and Jang Hyun Han. These partnerships have undoubtedly enriched her research endeavors and have contributed to advancements in the field of virology.

Conclusion

In summary, Amy J Weiner stands out as a significant figure in the realm of immunology and virology. With her impressive portfolio of patents and her collaborative efforts within prominent organizations, she continues to influence the development of effective treatments for viral infections. Her work not only addresses critical health challenges but also enhances our understanding of immune responses related to viral diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…